arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Anixa Biosciences, Inc.

ANIX Health Care Biotechnology: Pharmaceutical Preparations
$2.99
▲ +10.3% Today
as of Oct 23, 16:45 ET
Last 30 days +6.79% Sep 14 → Oct 23
$2.57 $2.69 $2.81 $2.93 $3.05 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.70
High
$2.78
Low
$2.69
Volume
$151,546
Avg Vol
$229,181
Mkt Cap
$96M
P/E (TTM)
—
Beta
—
52w High
$5.46
52w Low
$2.32
Div Yield
—
Shares Out
$35M

Recent Press Releases & News last 60 days · 9 items

Oct 13 · 13:00 PR ACCESS Newswire
Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
Oct 13 · 12:40 PR PR Newswire
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
Oct 5 · 12:15 PR PR Newswire
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
▸ Show all 9 press releases & news Free account →

ANIX earnings at a glance

The options market is pricing a move of about ±47.5% after the report, a range of roughly $1.57 to $4.41 from today's $2.99. Over its last 1 reports the stock rose the next day 1 time and fell 0, moving ±1.6% on average; after the most recent report on May 28, 2025 it moved +1.6%. That means options currently expect more movement than ANIX has typically delivered. ANIX beat the consensus EPS estimate in 2 of its last 2 reported quarters. Implied volatility is currently 304%. The share price of $2.99 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.32
$5.46
21% of range
Avg surprise (last 2)
+20.0%
Avg reaction (last 1)
+1.6%
100% positive
Latest IV / EM
304%
EM ±47.5% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.60$-0.34$-0.08$0.17$0.43 Actual $-0.07Actual $-0.08Actual $-0.10Actual $-0.10Actual $-0.10Actual $-0.10Actual $-0.09Est $-0.10Actual $-0.07Actual $-0.07Est $-0.10Actual $-0.08Actual $-0.07Actual $-0.08 AprJulJanAprJulJanApr/2025JulJul/2025JanAprJul
Revenue vs Net Income Revenue Net income
$-3M$-3M$-3M$-3M$-2M Jan 25Apr 25Jul 25Jan 26Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 31, 2026Jul 2026 $-0.08 — — — — financials
Thu Apr 30, 2026Apr 2026 $-0.07 — — — — financials
Sat Jan 31, 2026Jan 2026 $-0.08 — — — — financials
Wed Sep 10, 2025Jul/2025 $-0.07 $-0.10 +30.0% — — earnings
Thu Jul 31, 2025Jul 2025 $-0.07 — — — — financials
Wed May 28, 2025Apr/2025 $-0.09 $-0.10 +10.0% — +1.6% earnings
Fri Jan 31, 2025Jan 2025 $-0.10 — — — — financials
Wed Jul 31, 2024Jul 2024 $-0.10 — — — — financials
Tue Apr 30, 2024Apr 2024 $-0.10 — — — — financials
Wed Jan 31, 2024Jan 2024 $-0.10 — — — — financials
Mon Jul 31, 2023Jul 2023 $-0.08 — — — — financials
Sun Apr 30, 2023Apr 2023 $-0.07 — — — — financials
Tue Jan 31, 2023Jan 2023 $0.08 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-3M$-3M$-3M—$-2M$-3M$-3M—
Net income$-3M$-3M$-3M—$-2M$-3M$-3M—
EPS (diluted)$-0.08$-0.07$-0.08—$-0.07$-0.09$-0.10—

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Cash & equivalents$1M$1M$2M$1M$1M$2M$1M$1M
Inventory————————
Total current assets$15M$15M$15M$16M$17M$17M$19M$21M
Total assets$15M$15M$15M$16M$18M$17M$19M$22M
Long-term debt————————
Total liabilities$2M$2M$1M$2M$2M$2M$2M$3M
Total equity$14M$13M$14M$15M$15M$15M$17M$20M

Implied volatility — last 90 days

36%287%538%789%1040% Jun 09 — IV 347% · EM ±43.5%Jun 17 — IV 827% · EM ±34.5%Jun 19 — IV 152% · EM ±33.5%Jun 22 — IV 124% · EM ±25.9%Jun 23 — IV 129% · EM ±26.3%Jun 24 — IV 154% · EM ±30.8%Jun 25 — IV 136% · EM ±26.7%Jun 26 — IV 140% · EM ±26.9%Jun 29 — IV 119% · EM ±21.1%Jun 30 — IV 124% · EM ±21.4%Jul 01 — IV 257% · EM ±43.0%Jul 02 — IV 255% · EM ±41.3%Jul 03 — IV 264% · EM ±41.3%Jul 06 — IV 343% · EM ±47.5%Jul 07 — IV 269% · EM ±35.5%Jul 08 — IV 282% · EM ±35.4%Jul 09 — IV 381% · EM ±45.0%Jul 10 — IV 458% · EM ±50.7%Jul 13 — IV 509% · EM ±42.5%Jul 14 — IV 628% · EM ±45.5%Jul 15 — IV 1040% · EM ±61.4%Jul 16 — IV 974% · EM ±40.7%Jul 20 — IV 305% · EM ±72.0%Jul 22 — IV 36% · EM ±8.3%Jul 23 — IV 65% · EM ±14.7%Jul 24 — IV 104% · EM ±23.0%Jul 27 — IV 56% · EM ±11.6%Jul 29 — IV 416% · EM ±83.3%Jul 30 — IV 394% · EM ±77.2%Aug 11 — IV 388% · EM ±51.2%Aug 17 — IV 583% · EM ±48.7%Aug 18 — IV 927% · EM ±67.1%Aug 26 — IV 443% · EM ±88.8%Aug 27 — IV 448% · EM ±87.7%Sep 21 — IV 180% · EM ±37.6%Sep 22 — IV 158% · EM ±32.4%Sep 23 — IV 182% · EM ±36.4%Sep 24 — IV 174% · EM ±34.2%Sep 25 — IV 65% · EM ±12.4%Oct 01 — IV 324% · EM ±52.3%Oct 02 — IV 304% · EM ±47.5%

Sector peers

OKUR
OnKure Therapeutics, Inc.
$95M $2.52+9.6%
MIST
Milestone Pharmaceuticals Inc.
$102M $0.65-6.7%
RLYB
Rallybio Corporation
$90M $16.64+2.6%
ZSTK
ZeroStack Corp.
$104M $3.28-8.1%
ACRV
Acrivon Therapeutics, Inc.
$86M $1.73-5.2%
PMN
ProMIS Neurosciences Inc.
$84M $8.34-8.7%

ANIX earnings FAQ

What is ANIX's expected move for earnings?

Options currently price a move of about ±47.5%, or $1.42 per share either way from $2.99.

How does ANIX stock usually react to earnings?

Across the last 1 reports the average next-day move was ±1.6%, up 1 times and down 0 times.

What is ANIX's implied volatility?

ANIX's at-the-money implied volatility is about 304% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in